| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 23, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,340 | -- | 17,961 |
| Feb 23, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,396 | -- | 13,202 |
| Jun 06, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 5,127 | $70.46 | 10,495 |
| Jun 06, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,802 | $55.49 | 15,622 |
| Jun 06, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,802 | -- | -- |
| Feb 20, 2020 |
SVP Outcomes
|
SVP Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,210 | -- | 4,210 |
| Feb 24, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,171 | -- | 10,798 |
| Feb 18, 2021 |
SVP Outcomes
|
SVP Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,741 | -- | 8,726 |
| Dec 23, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 2,000 | $51.45 | 9,158 |
| Feb 23, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,913 | -- | 10,621 |
| May 12, 2020 |
SVP Outcomes
|
SVP Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 1,845 | $61.69 | 6,805 |
| Jun 06, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 1,404 | $71.06 | 9,091 |
| Feb 20, 2020 |
SVP Outcomes
|
SVP Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,289 | -- | 8,650 |
| Feb 18, 2021 |
SVP Outcomes
|
SVP Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,226 | -- | 5,985 |
| Feb 24, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,172 | -- | 11,970 |
| Feb 02, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 1,000 | $60.00 | 8,158 |
| Jul 31, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 983 | $63.16 | 10,074 |
| Jul 31, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 983 | $78.00 | 9,091 |
| Jul 31, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 983 | -- | -- |
| May 12, 2020 |
SVP Outcomes
|
SVP Outcomes | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 976 | $61.69 | 5,829 |
| Mar 01, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 903 | $55.52 | 10,820 |
| Feb 23, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 651 | -- | 8,236 |
| Feb 22, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 559 | $54.05 | 6,627 |
| Feb 11, 2020 |
SVP Outcomes
|
SVP Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 555 | $83.72 | 7,361 |
| Feb 23, 2021 |
SVP Outcomes
|
SVP Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 461 | $95.84 | 8,085 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.